672 related articles for article (PubMed ID: 28098802)
61. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
62. Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo.
Saraswati S; Alhaider AA; Agrawal SS
Chem Biol Interact; 2013 Nov; 206(2):204-13. PubMed ID: 24060680
[TBL] [Abstract][Full Text] [Related]
63. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
64. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.
Li M; Wu S; Liu Z; Zhang W; Xu J; Wang Y; Liu J; Zhang D; Tian H; Li Y; Ye W
Biochem Pharmacol; 2012 May; 83(9):1251-60. PubMed ID: 22305746
[TBL] [Abstract][Full Text] [Related]
65. Antrodia cinnamomea produces anti-angiogenic effects by inhibiting the VEGFR2 signaling pathway.
Huang TT; Lan YW; Ko YF; Chen CM; Lai HC; Ojcius DM; Martel J; Young JD; Chong KY
J Ethnopharmacol; 2018 Jun; 220():239-249. PubMed ID: 29609012
[TBL] [Abstract][Full Text] [Related]
66. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
67. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
[TBL] [Abstract][Full Text] [Related]
68. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
Ji L; Wu M; Li Z
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
[TBL] [Abstract][Full Text] [Related]
69. Boiled Abalone Byproduct Peptide Exhibits Anti-Tumor Activity in HT1080 Cells and HUVECs by Suppressing the Metastasis and Angiogenesis
Gong F; Chen MF; Chen J; Li C; Zhou C; Hong P; Sun S; Qian ZJ
J Agric Food Chem; 2019 Aug; 67(32):8855-8867. PubMed ID: 31343893
[TBL] [Abstract][Full Text] [Related]
70. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
[TBL] [Abstract][Full Text] [Related]
71. Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.
Wang S; Yang J; Kuang X; Li H; Du H; Wu Y; Xu F; Liu B
J Ethnopharmacol; 2024 May; 326():117913. PubMed ID: 38360380
[TBL] [Abstract][Full Text] [Related]
72. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
Yue GG; Lee JK; Kwok HF; Cheng L; Wong EC; Jiang L; Yu H; Leung HW; Wong YL; Leung PC; Fung KP; Lau CB
Sci Rep; 2015 Jun; 5():11149. PubMed ID: 26053458
[TBL] [Abstract][Full Text] [Related]
73. Erxian decoction, a traditional chinese herbal formula, inhibits angiogenesis in human umbilical vein endothelial cells.
Yu X; Tong Y; Huang W; Ge W
Biol Pharm Bull; 2013; 36(5):754-63. PubMed ID: 23391996
[TBL] [Abstract][Full Text] [Related]
74. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.
Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW
J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561
[TBL] [Abstract][Full Text] [Related]
75. Potent anti-angiogenic activity of B19--a mono-carbonyl analogue of curcumin.
Sun L; Liu J; Lin SS; Shi WT; Zhu J; Liang G; Yuan ST
Chin J Nat Med; 2014 Jan; 12(1):8-14. PubMed ID: 24484590
[TBL] [Abstract][Full Text] [Related]
76. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway.
Jiang JH; Pi J; Cai JY
Pathol Res Pract; 2020 Aug; 216(8):153031. PubMed ID: 32703495
[TBL] [Abstract][Full Text] [Related]
77. Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling.
Hu WH; Wang HY; Kong XP; Xiong QP; Poon KK; Xu L; Duan R; Chan GK; Dong TT; Tsim KW
FASEB J; 2019 Jan; 33(1):532-544. PubMed ID: 29989844
[TBL] [Abstract][Full Text] [Related]
78. The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway.
Guo GX; Wu KY; Zhang XY; Lai FX; Tsim KW; Qin QW; Hu WH
J Ethnopharmacol; 2023 May; 308():116299. PubMed ID: 36842721
[TBL] [Abstract][Full Text] [Related]
79. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
80. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
